The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > ARIAD Pharmaceuticals, Inc.

ARIAD Pharmaceuticals, Inc.
Nasdaq: ARIA
Change
symbol:
     
 PROFILE
ARIAD Pharmaceuticals is exploring biotechnology's myriad of possibilities. The firm's lead drug candidates target cancer, osteoporosis, anemia, and graft-versus-host disease (a complication of bone marrow transplantation); the drugs block or control cellular processes essential to the disease process. In addition to its four lead candidates, the company is developing gene and cell therapy technologies for autoimmune and inflammatory diseases. Its ARGENT, RPD, and RGE gene therapy technologies are licensed to researchers worldwide, including those scientists at such universities as Harvard and Stanford.

 COMPETITION
Chiron Corporation (CHIR)
Genzyme Corporation (GENZ)
Novartis AG (NVS)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: (99.2)%
Employees: 55
Revenue per employee: $1,818.18

 KEY PEOPLE
• Harvey J. Berger
    CEO
• Lee C. Steele
    CFO

 CONTACT INFO
26 Landsdowne St.
Cambridge, MA 02139
US
Phone: 617-494-0400
Fax: 617-494-8144
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001